Company

O2MEDi Inc.

O2MEDi develops photodynamic therapy products for resistant cancers.

About

Founded in 2020 and based in Ulsan, South Korea, O2MEDi develops photodynamic therapy products, including iridium-based photosensitizers intended to target resistant cancers such as pancreatic cancer. In November 2021, it received Seed funding from Creative Economy Innovation Center and SERIES VENTURES.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in